Publicacións nas que colabora con Beatriz Arrizabalaga Amuchastegui (4)

2014

  1. Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion

    British Journal of Haematology, Vol. 166, Núm. 2, pp. 189-201

  2. Transfusion dependence development and disease evolution in patients with MDS and del(5q) and without transfusion needs at diagnosis

    Leukemia Research, Vol. 38, Núm. 3, pp. 304-309

2010

  1. Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements

    Annals of Hematology, Vol. 89, Núm. 2, pp. 147-154

2009

  1. P030 Prognostic impact on survival of an unsuccessful conventional cytogenetic study in patients with myelodysplastic syndromes (MDS)

    Leukemia Research, Vol. 33, Núm. SUPPL. 1